Macrovic: Uses, Dosage & Side Effects

What Is Macrovic and What Is It Used For?

Macrovic contains macrogol, also known internationally as polyethylene glycol (PEG), as its active pharmaceutical ingredient. Macrogol is a long-chain polymer composed of ethylene oxide subunits, and it has been used in medicine for decades due to its unique physicochemical properties. When taken orally as a solution, macrogol acts as an osmotic agent within the gastrointestinal tract, meaning it draws and retains water in the colonic lumen through osmotic forces. This mechanism of action is entirely local — macrogol is not absorbed through the intestinal wall into the bloodstream, is not metabolized by the body, and is excreted unchanged in the feces.

The osmotic effect of macrogol increases the water content of the stool, making it softer and easier to pass. Simultaneously, the increased volume of intestinal contents stretches the colon wall, which activates mechanoreceptors and stimulates peristalsis — the coordinated wave-like contractions of the intestinal muscles that move contents along the digestive tract. This dual mechanism (stool softening plus stimulation of natural peristaltic reflexes) makes macrogol particularly effective as a laxative, as it works with the body's natural physiology rather than through chemical irritation of the gut wall.

Macrovic is indicated for the following conditions:

• Chronic constipation: Macrovic is a first-line treatment for chronic functional constipation in adults and children. Chronic constipation is defined as the persistent difficulty in passing stools, infrequent bowel movements (typically fewer than three per week), or a sensation of incomplete evacuation. It affects an estimated 10–15% of the global adult population and is even more prevalent among elderly individuals. Macrogol-based laxatives are recommended as a first-line pharmacological therapy for chronic constipation by multiple international guidelines, including the World Gastroenterology Organisation (WGO), the American Gastroenterological Association (AGA), and the British Society of Gastroenterology (BSG).
• Fecal impaction: At higher doses, macrogol can be used to treat fecal impaction, a condition where a large, hardened mass of stool becomes stuck in the colon or rectum and cannot be passed naturally. Fecal impaction is particularly common in elderly patients, those with reduced mobility, and individuals taking opioid medications. Macrogol-based solutions are effective in dissolving and softening impacted fecal matter, allowing it to be passed without the need for manual disimpaction in many cases.
• Bowel preparation before diagnostic procedures: Macrogol-based solutions, often in combination with electrolytes, are widely used as bowel cleansing agents before colonoscopy, barium enema, or other gastrointestinal investigations. Effective bowel preparation is essential for adequate visualization of the colonic mucosa during these procedures. The volume-based approach using macrogol solutions ensures thorough cleansing of the entire colon.

The clinical efficacy of macrogol in treating constipation is supported by extensive evidence, including multiple systematic reviews and meta-analyses. A landmark Cochrane systematic review encompassing 10 randomized controlled trials with 868 participants found that macrogol significantly increased stool frequency and improved stool consistency compared with both placebo and other commonly used laxatives such as lactulose. The review concluded that macrogol was superior to lactulose in terms of stool frequency, stool form, relief of abdominal pain, and the need for additional laxative products. These findings have been consistently replicated in subsequent studies and are reflected in current international treatment guidelines.

In pediatric populations, macrogol has become the gold standard treatment for childhood constipation, a condition that accounts for approximately 3–5% of all pediatric outpatient visits and up to 25% of pediatric gastroenterology consultations worldwide. The National Institute for Health and Care Excellence (NICE) in the United Kingdom, along with the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN), all recommend macrogol as the first-line pharmacological treatment for constipation in children.

What Should You Know Before Taking Macrovic?

Contraindications

Macrovic must not be used in patients with certain gastrointestinal conditions where the introduction of additional fluid volume into the bowel could be harmful. The following are absolute contraindications to the use of Macrovic:

• Intestinal obstruction (ileus): If there is a mechanical blockage preventing the normal passage of intestinal contents, adding volume and fluid to the system could increase intraluminal pressure, potentially leading to perforation. Symptoms of intestinal obstruction include severe abdominal pain, vomiting, absolute constipation (inability to pass stool or gas), and abdominal distension.
• Gastrointestinal perforation: Any known or suspected perforation of the gastrointestinal tract is an absolute contraindication, as leakage of bowel contents into the peritoneal cavity can cause life-threatening peritonitis.
• Severe inflammatory bowel disease: Active severe ulcerative colitis, Crohn's disease, or toxic megacolon represent conditions where the integrity of the bowel wall is compromised. The additional fluid load from macrogol could worsen inflammation or precipitate dangerous complications such as toxic dilatation.
• Hypersensitivity: Known allergy to macrogol (polyethylene glycol) or to any of the other excipients in the formulation. Although rare, allergic reactions to macrogol have been reported, ranging from mild skin reactions to anaphylaxis.

Warnings and Precautions

Before starting treatment with Macrovic, your doctor should be informed about the following:

• Underlying organic causes: Constipation can sometimes be a symptom of a more serious underlying condition, such as colorectal cancer, hypothyroidism, or neurological disorders. Your doctor may wish to investigate the cause of your constipation before prescribing a laxative, particularly if you experience a sudden change in bowel habits, unexplained weight loss, rectal bleeding, or if you are over 50 years of age and have not had recent bowel cancer screening.
• Fluid and electrolyte balance: When used at standard doses for constipation, macrogol formulations containing electrolytes are designed to maintain electrolyte balance and are considered safe. However, when used at higher doses for bowel preparation or fecal impaction, the large volumes of fluid involved can potentially affect fluid and electrolyte homeostasis, particularly in elderly patients, those with renal impairment, or patients taking diuretics. Monitoring may be appropriate in these populations.
• Nausea and vomiting: Some patients experience nausea when drinking the macrogol solution, particularly when consuming large volumes for bowel preparation. If nausea is severe, slow down the rate of ingestion or pause temporarily. Persistent vomiting should be reported to your doctor, as it may impair the effectiveness of the bowel preparation.
• Heart conditions: Patients with significant cardiac disease (especially heart failure) should be monitored when using large-volume macrogol preparations for bowel cleansing, as the absorbed fluid load could potentially exacerbate fluid overload. Standard doses for constipation treatment are generally not associated with this risk.

Pregnancy and Breastfeeding

Constipation is a very common complaint during pregnancy, affecting up to 40% of pregnant women due to hormonal changes (particularly elevated progesterone levels), reduced physical activity, iron supplementation, and mechanical compression of the bowel by the growing uterus. Macrogol is generally considered safe for use during pregnancy because it is not absorbed from the gastrointestinal tract into the bloodstream. Since it does not enter the systemic circulation, it cannot cross the placenta and reach the developing fetus.

Extensive clinical experience with macrogol-based products in pregnant women has not revealed any increased risk of adverse effects on the mother or the fetus. However, as with all medications used during pregnancy, macrogol should only be used when the benefits of treatment are considered to outweigh any potential risks, and after lifestyle modifications (increased dietary fiber, adequate fluid intake, regular physical activity) have been attempted. Your doctor or midwife can provide personalized guidance on the management of constipation during pregnancy.

Similarly, macrogol is considered compatible with breastfeeding. Since it is not absorbed systemically, it does not enter breast milk and therefore poses no risk to the nursing infant. If you are breastfeeding and experiencing constipation, Macrovic may be a suitable treatment option after discussion with your healthcare provider.

Use in Children

Macrogol-based products are widely prescribed for constipation in children, typically from the age of 2 years and older, depending on the specific formulation and local prescribing guidelines. Childhood constipation is one of the most common gastrointestinal complaints in pediatric practice, and macrogol has been shown to be more effective than lactulose in systematic reviews of pediatric constipation. The dose for children is lower than for adults and should be carefully titrated based on age, weight, and clinical response. Macrogol should not be used in children without medical supervision, and the underlying cause of constipation should be evaluated by a healthcare professional, particularly in infants and very young children.

Driving and Operating Machinery

Macrovic has no known influence on the ability to drive or operate machinery. Since the active substance is not absorbed into the bloodstream and acts only locally in the gut, it does not affect the central nervous system or cause drowsiness, dizziness, or other neurological effects that might impair these abilities.

How Does Macrovic Interact with Other Drugs?

Unlike many medications that interact through enzymatic pathways (such as cytochrome P450 metabolism), Macrovic does not undergo metabolic transformation and is not absorbed systemically. Therefore, it does not interfere with other drugs through traditional pharmacokinetic drug-drug interaction mechanisms involving hepatic enzymes, protein binding, or renal excretion. However, there is a clinically relevant interaction mechanism that must be considered: the effect of macrogol on the gastrointestinal absorption of co-administered oral medications.

Macrogol increases the volume of fluid in the intestinal lumen and can accelerate gastrointestinal transit time. This means that other oral medications taken at the same time as Macrovic may pass through the gastrointestinal tract more rapidly than usual, potentially reducing their time available for absorption and thereby decreasing their bioavailability. This effect is particularly significant for medications that are absorbed slowly, have a narrow absorption window in the gastrointestinal tract, or have a narrow therapeutic index where even small changes in blood levels can affect efficacy or safety.

The general recommendation is straightforward: take any other oral medications at least 1 hour before or at least 2 hours after taking Macrovic. This timing separation allows the co-administered medication to be adequately absorbed before the osmotic effects of macrogol take hold. For medications with a particularly narrow therapeutic index (such as anti-epileptic drugs, digoxin, or immunosuppressants), it may be advisable to monitor drug levels more frequently when starting or adjusting Macrovic therapy, and to maintain consistent timing between the two medications.

It is important to note that this absorption interaction is a class effect shared by all osmotic and bulk-forming laxatives, and is not specific to macrogol. Any laxative that increases gastrointestinal transit speed can potentially reduce the absorption of co-administered oral medications. If you are taking multiple medications, discuss the optimal timing schedule with your doctor or pharmacist to ensure that each medication has the best chance of being fully absorbed.

What Is the Correct Dosage of Macrovic?

Macrovic should always be used exactly as your doctor or pharmacist has instructed. The powder must be completely dissolved in the recommended volume of water before drinking. Do not take the powder dry or with insufficient water, as the osmotic effect depends on adequate hydration. The solution should be consumed promptly after preparation.

Adults

For chronic constipation, treatment is typically started at the lower end of the dose range (1 sachet daily) and adjusted upward if needed. The goal is to achieve comfortable, regular bowel movements without causing loose stools or diarrhea. Many patients find that they can reduce the dose to a maintenance level once regular bowel habits are established. The dose should be the lowest effective dose needed to maintain comfortable bowel function.

When preparing the solution, dissolve each sachet in the recommended volume of water (typically 125 mL per sachet, though this may vary by formulation — always follow the instructions on the packaging). Stir the solution until the powder is fully dissolved. The solution may be consumed at any time of day, though many patients find it most convenient to take it in the morning with breakfast or in the evening. You may chill the solution in the refrigerator to improve palatability if desired.

Children

Elderly Patients

No dose adjustment is generally required for elderly patients. However, elderly individuals may be more susceptible to fluid and electrolyte disturbances, particularly when using higher doses for fecal impaction or bowel preparation. In such cases, medical supervision and monitoring of hydration status and serum electrolytes may be appropriate. Starting at the lower end of the dose range and titrating upward based on response is advisable in elderly patients.

Missed Dose

If you forget to take a dose of Macrovic, take it as soon as you remember. If it is nearly time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one. Missing an occasional dose is unlikely to cause problems, but consistent daily use is important for maintaining regular bowel function in patients with chronic constipation.

Overdose

Taking too much Macrovic can cause excessive diarrhea, abdominal pain, and nausea. Severe overdose with large-volume macrogol solutions can potentially lead to fluid and electrolyte imbalances, particularly dehydration and hyponatremia (low sodium levels). If significant overdose occurs, stop taking Macrovic, ensure adequate oral fluid replacement, and seek medical advice. In most cases, symptoms of mild overdose resolve spontaneously once the excess macrogol has been eliminated from the body. Severe cases may require intravenous fluid and electrolyte replacement in a medical setting.

What Are the Side Effects of Macrovic?

Like all medicines, Macrovic can cause side effects, although not everybody gets them. The vast majority of side effects associated with macrogol are related to its mechanism of action in the gastrointestinal tract and are dose-dependent — they are more likely to occur at higher doses and tend to resolve with dose reduction or discontinuation. Since macrogol is not absorbed systemically, systemic side effects are exceptionally rare.

The following side effects have been reported in clinical trials and post-marketing surveillance with macrogol-based products. They are classified according to their frequency using the standard medical convention:

The gastrointestinal side effects of Macrovic are typically most noticeable during the first few days of treatment and tend to diminish as the body adjusts. If bloating or abdominal discomfort is bothersome, your doctor may recommend starting at a lower dose and gradually increasing it. Diarrhea usually indicates that the dose is too high and can be managed by reducing the dose. If diarrhea persists despite dose reduction, discontinue Macrovic and consult your doctor.

Allergic reactions to macrogol (polyethylene glycol) are rare but have been increasingly recognized in recent years. PEG is present in many pharmaceutical and cosmetic products, and cross-reactivity can occur. If you experience skin rash, itching, swelling of the face or throat, difficulty breathing, or other signs of an allergic reaction after taking Macrovic, stop taking it immediately and seek medical attention. Patients with a known allergy to polyethylene glycol should not use Macrovic.

When used at standard doses for constipation, macrogol formulations containing electrolytes do not cause clinically significant changes in serum electrolyte levels. This is an important advantage over some other laxatives (such as magnesium-containing products or stimulant laxatives with chronic use) that can disrupt electrolyte balance. However, when used at higher doses for bowel preparation or prolonged high-dose use for fecal impaction, electrolyte monitoring may be warranted, particularly in vulnerable populations such as elderly patients or those with renal impairment.

How Should You Store Macrovic?

Proper storage of Macrovic is important to ensure that the medication remains effective and safe to use throughout its shelf life. The following guidelines should be followed:

• Temperature: Store the unopened sachets at room temperature, below 25°C (77°F). Do not expose the sachets to excessive heat or freezing temperatures. Brief exposure to temperatures above 25°C (for example, during transportation) is generally not harmful, but prolonged exposure should be avoided.
• Moisture: Keep the sachets in their original packaging to protect them from moisture. Macrogol is hygroscopic (it absorbs moisture from the air), and exposure to humidity can cause the powder to clump or degrade. Do not store the sachets in the bathroom, near a sink, or in other areas with high humidity.
• Light: Protect the sachets from direct sunlight. While macrogol is relatively stable to light, prolonged exposure to intense sunlight can affect the integrity of the packaging.
• Prepared solution: Once the powder has been dissolved in water, the solution should ideally be consumed immediately. If it is not consumed right away, the prepared solution may be covered and stored in the refrigerator (2–8°C) for up to 24 hours. Discard any unused solution after 24 hours. Chilling the solution in the refrigerator can also improve its taste and palatability.
• Keep out of reach of children: As with all medicines, store Macrovic in a safe place where children cannot access it.
• Expiry date: Do not use Macrovic after the expiry date printed on the sachet and outer packaging. The expiry date refers to the last day of the stated month.

Do not dispose of medicines via household waste or wastewater. Ask your pharmacist how to dispose of medicines you no longer use. These measures help protect the environment and prevent accidental exposure.

What Does Macrovic Contain?

Each sachet of Macrovic contains the following components:

Active Ingredient

• Macrogol (Polyethylene Glycol): The primary active substance. Macrogol is a synthetic, water-soluble polymer of ethylene oxide. It is chemically inert, non-toxic, and non-immunogenic. Different formulations use different molecular weights of macrogol (commonly macrogol 3350 or macrogol 4000), which determines the osmotic properties of the solution. The macrogol used in laxative preparations has a molecular weight high enough that it is not absorbed through the intestinal mucosa.

Electrolytes (if present in formulation)

Many macrogol-based laxative preparations, including some formulations of Macrovic, contain supplementary electrolytes to prevent the net loss of sodium, potassium, and bicarbonate that could theoretically occur when large volumes of fluid pass through the colon. These electrolytes may include:

• Sodium chloride: Maintains sodium balance
• Sodium bicarbonate: Provides buffering capacity and helps maintain acid-base balance
• Potassium chloride: Prevents potassium depletion

Other Ingredients (Excipients)

The powder may also contain the following inactive ingredients to improve the taste, stability, and ease of preparation of the solution:

• Flavoring agents (such as lemon, orange, or other fruit flavors)
• Sweeteners (such as acesulfame potassium or saccharin sodium)
• Colloidal silicon dioxide (anti-caking agent)

The exact composition of excipients may vary between different batches and formulations. Always check the patient information leaflet included with your specific product for the complete list of ingredients, particularly if you have known allergies or intolerances to any food additives, artificial sweeteners, or flavoring agents.